Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation (Q27634946)

Cholinergic receptor muscarinic 2

23 March 2017

main subject

crystal structure

0 references

1 reference

arrestin family protein binding

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

Vsevolod V Gurevich

2 references

ORCID Public Data File 2021

23 March 2017

May Han

1 reference

23 March 2017

Sergey A Vishnivetskiy

series ordinal

1 reference

23 March 2017

Paul B Sigler

series ordinal

1 reference

23 March 2017

Carsten Schubert

series ordinal

1 reference

23 March 2017

language of work or name

English

0 references

publication date

September 2001

1 reference

23 March 2017

1 reference

23 March 2017

volume

1 reference

23 March 2017

issue

1 reference

23 March 2017

page(s)

869-880

1 reference

The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation

23 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

X-ray crystal structure of arrestin from bovine rod outer segments

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Dynamin and beta-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Identification of NSF as a beta-arrestin1-binding protein. Implications for beta2-adrenergic receptor regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Enhanced morphine analgesia in mice lacking beta-arrestin 2

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Arrestin interactions with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, beta 2-adrenergic, and m2 muscarinic cholinergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Targeted construction of phosphorylation-independent beta-arrestin mutants with constitutive activity in cells

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Molecular cloning, functional expression and mRNA analysis of human beta-adrenergic receptor kinase 2

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

How does arrestin respond to the phosphorylated state of rhodopsin?

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Identification of T cell recognition sites in S-antigen: dissociation of proliferative and pathogenic sites

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

An additional phosphate-binding element in arrestin molecule. Implications for the mechanism of arrestin activation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Topographic study of arrestin using differential chemical modifications and hydrogen/deuterium exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Visual arrestin activity may be regulated by self-association

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

The interpretation of protein structures: Estimation of static accessibility

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Protein complement of rod outer segments of frog retina

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Interactions of metarhodopsin II. Arrestin peptides compete with arrestin and transducin.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

A segment corresponding to amino acids Val170-Arg182 of bovine arrestin is capable of binding to phosphorylated rhodopsin.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Visual arrestin binding to rhodopsin. Diverse functional roles of positively charged residues within the phosphorylation-recognition region of arrestin.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Mechanism of phosphorylation-recognition by visual arrestin and the transition of arrestin into a high affinity binding state

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Binding of arrestin to cytoplasmic loop mutants of bovine rhodopsin

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Seven non-contiguous intracellular residues of the lutropin/choriogonadotropin receptor dictate the rate of agonist-induced internalization and its sensitivity to non-visual arrestins

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Amphitropic proteins: regulation by reversible membrane interactions (review).

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Structure of the human ADP-ribosylation factor 1 complexed with GDP

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Structural Basis for Activation of ARF GTPase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

N-terminal hydrophobic residues of the G-protein ADP-ribosylation factor-1 insert into membrane phospholipids upon GDP to GTP exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Crystal structure of rhodopsin: A G protein-coupled receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

The 2.0 A crystal structure of a heterotrimeric G protein

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Isoprenylation in regulation of signal transduction by G-protein-coupled receptor kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

The membrane association domain of RGS16 contains unique amphipathic features that are conserved in RGS4 and RGS5

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

RGS4 binds to membranes through an amphipathic alpha -helix.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Molecular mechanics of calcium-myristoyl switches

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Kinetics, binding constant, and activation energy of the 48-kDa protein-rhodopsin complex by extra-metarhodopsin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Functional Differences in the Interaction of Arrestin and Its Splice Variant, p44, with Rhodopsin

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Rapid and reproducible deactivation of rhodopsin requires multiple phosphorylation sites

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Arrestin/clathrin interaction. Localization of the clathrin binding domain of nonvisual arrestins to the carboxy terminus

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Agonist-receptor-arrestin, an alternative ternary complex with high agonist affinity.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Culture medium for enterobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

The CCP4 suite: programs for protein crystallography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Methods used in the structure determination of bovine mitochondrial F1 ATPase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Improved methods for building protein models in electron density maps and the location of errors in these models

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

Free R value: a novel statistical quantity for assessing the accuracy of crystal structures

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

PROCHECK: a program to check the stereochemical quality of protein structures

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2801%2900644-X

7 January 2021

10.1016/S0969-2126(01)00644-X

Identifiers

DOI

2 references

23 March 2017

Consolidated OpenCitations Corpus – April 2017

435056

Consolidated OpenCitations Corpus – April 2017

2 references

435056

PubMed publication ID

11566136

1 reference

Consolidated OpenCitations Corpus – April 2017